ADAMTS1 and metastatic neoplasm: ADAMTS-1 expression was typically decreased in PrCa samples, patients with metastatic disease, and a PrCa cell line variant with higher metastatic potential but elevated in slower-growing PrCa tumors in mice [65,179,219,220].